February 10, 2021; 6 - 7 p.m., CST

Substance Use Disorders, Substance Induced Disorders and Co-Occurring(ETHICS)

Individuals with both a substance use disorder and a mental disorder constitute an especially challenging diagnostic and treatment group. This presentation will shed light on this topic as it reviews the epidemiology, diagnosis, prognosis and some treatment ideas. Clinical vigilance is the key to unlocking these complicated differential diagnoses that as a group are labeled co-occurring disorders.

Learning Objectives:

  • Learn about common co-occurring and substance induced disorders
  • Understand the factors contributing to co-occurring and substance induced disorders
  • Review DSM-V diagnostic criteria
 

SPEAKER

 

R. Gregory Lande, DO, FACN, FAOAAM

Dr. R. Gregory Lande, DO, FACN, FAOAAM

Dr. Lande is a Psychiatry and Behavioral Sciences Clinical Investor. In addition, he serves as Editor-in-Chief of Journal of Addictive Diseases; Trustee for the American Osteopathic Academy of Addictive Medicine, and serves on the Editorial Board for the Journal of the American Osteopathic Association.  

Dr. Lande is the author of numerous articles, chapters and books. His most recent book is the "Abraham Man: Madness, Malingering and the Growth of Medical testimony".

 

ANTICIPATED CREDITS

1 AOA Category 1-A credit, including 1 ethics credit

FEES

FREE for TOMA members; $35 for non-members

ON-DEMAND OPTION

We know schedules get hectic and things happen. Approximately 1 week after the live session, an on-demand recording will be available.